A second probable case of fungal meningitis in Chicago tied to the use of a steroid injection from a Massachusetts pharmacy is being investigated by health officials.
As in the first case in the state, the case reported Friday involves a Chicago resident who received an injection at one of three APAC Centers for Pain Management that used the recalled medication, according to officials.
Officials didn’t release any details about the person sickened, but said the injections took place between May 21 and Sept. 26, the period during which the Centers for Disease Control and Prevention has warned the recalled medications may have been dangerous. The patient is still being tested and treated, according to a release from the Illinois Department of Public Health.
The company at the center of the national fungal meningitis outbreak, the New England Compounding Center in Massachusetts, has recalled all of its products going back to the first of the year. Federal health officials have found The company’s state license was suspended last month.
“We are still encouraging anybody who has received an epidural steroid injection and is experiencing fever, headache, stiff neck, sensitivity to light, new numbness or weakness, or slurred speech, to see a doctor immediately,” state Health Director Director Dr. LaMar Hasbrouck said in the release. “This type of fungal meningitis is not contagious.”
As of Nov. 2, 409 people have become sick and 29 people have died in the outbreak of fungal meningitis, according to the CDC.